CLINICAL_TRIALS
ClinicalTrials.gov record update
A Single Arm Phase II Study to Evaluate Efficacy of T-DM1 With Palbociclib in the Treatment of Patients With Metastatic HER2 Positive Breast Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03530696
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:17.633584+00:00
- Published At
- 2024-07-24T00:00:00+00:00
- Record Updated At
- 2024-08-13
- Results Posted At
- 2024-07-24
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["HER2-positive Breast Cancer", "Breast Cancer", "Breast Cancer Stage", "Recurrent Breast Cancer", "Metastatic Breast Cancer", "HER2 Positive Breast Carcinoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-08-13"- protocolSection.identificationModule.nctId
"NCT03530696"- protocolSection.identificationModule.officialTitle
"A Single Arm Phase II Study to Evaluate Efficacy of T-DM1 With Palbociclib in the Treatment of Patients With Metastatic HER2 Positive Breast Cancer"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-07-24"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.